ImmuPharma PLC announced that Dr Franco di Muzio, Senior Non-Executive Director ('NED') and Dr Stéphane Méry, ('NED'), have also decided that now is an appropriate time for each of them to step down from the Board following 14 and 6 years in these roles respectively. The company appointed of Dr Sanjeev Pandya as Senior independent NED. Sanjeev has over 25 years of healthcare and international management experience. Sanjeev was formerly CEO of Advanced Oncotherapy Plc, a specialist cancer radiotherapy business listed on AIM. In addition, Lisa Baderoon has been appointed to the Board as a NED. Lisa has been advising the company since its flotation on AIM in 2006 and was appointed Head of Investor Relations in 2012. Lisa's key activities over the last period have been in providing strategic advice to the Board and liaising with investors, stakeholders and advisors of the company.